Advances in treating COVID-19 have come piecemeal, but recent clinical trials have pointed to several additional drugs that could join the #COVID19 tool kit https://t.co/fsOv7mAkh3
— National Geographic (@NatGeo) February 25, 2021
"We don’t have anything for [patients with progressive severe or critical COVID-19] and this is at least one thing that is available which might have a modest benefit,” says IDSA #COVID19Guidelines panelist @adarsh_bhimraj about #tocilizumab. https://t.co/fnHUTJJg0y
— IDSA (@IDSAInfo) February 23, 2021
https://twitter.com/IDSAInfo/status/1357882837370822656
https://twitter.com/CLENeurons/status/1294331665565855750
https://twitter.com/PawlowskiMario/status/1364096797564686336
#OXIG+2% £15.88
10 brand new #technologies that are emerging in 2020
by @FrRonconi#4IR #EmergingTech #AI #SpaceTech #Pharma #Longevity #Drugs #HealthTech #PersonalisedMedicines #ML #DigitalMoney #Fintech #QuantumComputing #FutureWork #Investing pic.twitter.com/cdHUTcIgyo— Peter Higgins (conkers) (@conkers3) September 8, 2020
https://twitter.com/SwissCognitive/status/1365381151423148033
Galileo once observed that nature is written in math. Biology might be written in words—and artificial intelligence can now read it to catch covid-19 mutations. https://t.co/EBJdsRnns1
— MIT Technology Review (@techreview) February 22, 2021
Scientists are using #AI to help recommend antiviral drugs ✨- Unlocking the potential of #ML by @spell_ml #DL #BigData cc @DrJDrooghaag @NevilleGaunt @BetaMoroney @Nicochan33 @sallyeaves @Victoryabro @PawlowskiMario @FrRonconi @FmFrancoise @MasterofIoT pic.twitter.com/116IdH4R9q
— Ian Jones (@IanLJones98) July 21, 2020
"As tuberculosis shaped modernism, so covid-19 and our collective experience of staying inside for months on end will influence architecture’s near future."https://t.co/lkj0OqtuIm
— AIA Pittsburgh (@AIApgh) February 22, 2021
Raloxifene, a generic drug used to treat osteoporosis, was identified as a potential drug for #COVID19. Scientists, among them ERC grantee Marcin Nowotny @IIMCB_Poland, used supercomputers and #AI to break new ground in the fight against the #coronavirus. https://t.co/nBUzGNTlkU pic.twitter.com/OW3GzoAK63
— European Research Council (ERC) (@ERC_Research) June 18, 2020
Eclipsed by the exciting $MRNA vaccine news, an AI program predicted the drug baricitinib would ‘reduce the ability of the virus to infect lung cells’. Arthritis drug 'cuts elderly Covid-19 deaths by two-thirds' h/t: @fundstrat https://t.co/HtutredOSD
— Hal Bringman (@halbringman) November 16, 2020
How Existing Drugs Could Be Repurposed Using #AI To Fight #COVID19 #pandemic #vaccine #healthtech #healthcare #machinelearning #technews #Medical #coronavirus #astrazenecavaccine #100daysofcode #bigdata #technology@SpirosMargaris @Ronald_vanLoon https://t.co/HQkvjLQUPD
— Analytics India Magazine (@Analyticsindiam) February 20, 2021
What #coronavirus symptoms look like, day by day @irmaraste @eViRaHealth #CoronaVirus #CoronaVirusOutbreak #COVID2019 #covid19 #medtwitter #CoronaVirusChallenge #Corona pic.twitter.com/HV7uX240mu
— Maliha khan (@malihadubai) March 19, 2020
Oxford firm to screen 15,000 drugs in search for coronavirus cure
Exscientia to use AI to hunt through compounds which have passed human trialshttps://t.co/UYCJzlHekV
— Socialist Voice (@SocialistVoice) March 31, 2020
Japanese supercomputer finds 30 existing drugs potentially effective to treat #COVID-19!
https://t.co/EOSzXqscAX #Tech #BioTech #AI #MachineLearning #ML #DL #DeepLearning #Science #Data #DataScience #PublicHealth #Health #Medicine #MedicalScience #Coronavirus #COVID19
— Dr. Joseph Santoro (@Joseph_Santoro) July 5, 2020
Scientists at @WesternU in Canada leveraging #AI & #ML to identify an underlying genomic signature for 29 different DNA sequences of the novel coronavirus is a significant milestone on the path towards developing vaccine and potential drugs for #COVID19.https://t.co/sFI5POp4kM
— Dr.Omkar Rai (@Omkar_Raii) April 30, 2020
#AI can play an extraordinary role in fighting #COVID19 by predicting coronavirus hotspots, accelerating diagnostic process and enabling scientists & pharmaceutical companies deepen R&D and develop effective drugs & vaccines faster.https://t.co/gKI6rytYOy
— Dr.Omkar Rai (@Omkar_Raii) March 31, 2020
August summer issue: https://t.co/ccSY5Qlf4d…
Don't miss our articles on AI & baricitinib, optical #cochlearimplant (our gorgeous cover), antifungal immunity, #pancreatitis, #DuchenneMuscularDystrophy, #axonregeneration, #pulmonaryfibrosis, combination therapy for #TNBC and more pic.twitter.com/TGv4MBs7qV— EMBO Mol. Medicine (@EmboMolMed) August 12, 2020
News: NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins https://t.co/8hh4rQHNKO
— NIH (@NIH) May 8, 2020
Our recommendations for using #baricitinib are based on data from ACTT-2, a trial that enrolled hospitalized patients with #COVID19 pneumonia. We discuss the results of this trial in our section on kinase inhibitors: https://t.co/HBqu513tFB
— NIH COVID-19 Treatment Guidelines (@NIHCOVIDTxGuide) February 22, 2021
Missed this. It is interesting. I want to see full results but intriguing…
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients https://t.co/wuqWyFMfie
— Ethan Weiss (@ethanjweiss) January 23, 2021
In February, the #RECOVERYtrial began investigating the drug #baricitinib as a potential treatment for hospitalised #COVID19 patients; and reported that #tocilizumab reduces deaths in patients hospitalised with COVID-19. More in Research Bulletin: https://t.co/8p0soXocIw pic.twitter.com/kMXpKXeyun
— NHS Research Scotland (@NHSResearchScot) February 25, 2021
Exciting news coming out of a London startup where a team of AI scientists helped to identify an arthritis drug called Baricitinib that could be a possible Coronavirus treatment and is now heading to an accelerated clinical trialhttps://t.co/ND66TOMjtl
— RazorThink (@RazorThinkAI) May 1, 2020
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients https://t.co/qKtNF1pkvl #DHPSP #ArtificialIntelligence #AI pic.twitter.com/Umbjg9pN8Q
— Digital Health and Patient Safety Platform (@DHPSP) June 29, 2020
New by @Medivizor: Baricitinib may effectively slow down progression of joint damage in patients with RA https://t.co/fjydj1nJYm #Rheum
— Medivizor (@medivizor) February 22, 2021
Don't go running to the doctor yet, but #Baricitinib was identified by #AI as a potential treatment for #coronavirus.
Stay tuned.https://t.co/bk0V3YnwF9
— The Politerate (@ThePoliterate) April 17, 2020
A startup in the #UK has used AI to analyze different drugs for #Covid19. It found an arthritis medicine (baricitinib) that could reduce mortality in elderly patients. In one study, baricitinib brought down the mortality rate by 71%. https://t.co/HL1cS6o0KS
— CIF (@cifglobal) November 24, 2020
Montreal Heart Institute’s COLCORONA Trial Reveals Colchicine Treats Reduces Hospitalization & Death Rates Associated with COVID-19https://t.co/09wQ9p5Fjd#Colchicine #COLCORONA #COVID-19 #MHI pic.twitter.com/9VqiIpB2Df
— TrialSite News (@TrialsiteN) January 24, 2021
Jean-Claude Tardif, head of the Montreal Heart Institute (ICM), led the study named "Colcorona," whose preliminary results were published Friday evening. https://t.co/lvXqA1jwuj
— The Philippine Star (@PhilippineStar) January 25, 2021
NYU & Montreal Heart Instit. teaming on the COLCORONA study of Colchicine in early phase COVID-19 infx. TBD in 6,000 patients with mild forms of the disease. Dr. M Pillinger says colchicine, early on, may inhibit damaging inflammatory responses https://t.co/UTW2g6QU2r
— Dr. John Cush (@RheumNow) April 20, 2020
#BRCtenantNews In Feb @benevolent_ai published its research finding that #baricitinib could be a potential #covid19 treatment. Initial clinical data supporting this hypothesis in collaboration with @LillyPad scientists has been published in @EmboMolMed https://t.co/lkPpKfX7m4 pic.twitter.com/ft9OVxBJlK
— Babraham Research Campus (@BabrahamUK) July 16, 2020
Four new studies show #AI-discovered rheumatoid drug effective at treating #COVID19—If Baricitinib is proven effective it will be a boost for @benevolent_ai | via @Siftedeu https://t.co/ltMQDfWD3J
— Rob McCargow (@RobMcCargow) July 3, 2020
The COLCORONA RCT is on medRxiv …
The study was stopped early (76 % inclusion interim analysis) due to a logistical issue.
The primary endpoint is not significantly different ! Only in PCR positive patients (an apparently presp…https://t.co/CYxyXyHOZh https://t.co/zJBh07lxrU
— Thierry Fumeaux (@tfumeaux) January 27, 2021
https://twitter.com/CanEmbSpain/status/1245644691485290497
"It still makes the hair stand up at the back of my neck, thinking about it,” says Peter Richardson, our VP Pharmacology, describing the moment when he realised that #baricitinib could be an effective treatment for #COVID19. Read more in @Siftedeu: https://t.co/TPZxuVSwm4
— BenevolentAI (@benevolent_ai) April 16, 2020
Pharmaco-Immunomodulatory Therapy in #COVID-19#Immunomodulators are increasingly being studied in COVID-19 #colchicine, #tocilizumab (combination with #dexamethasone), #baricitinib (combination with #remdesivir) https://t.co/ZT2j4f6ZDQ @COVID19_USA_ @WHCOVIDResponse pic.twitter.com/YCgKmYslwY
— Kam Kalantar-Zadeh, MD, MPH, PhD (@kamkalantar) February 20, 2021
Baricitinib has been granted Emergency Use Authorization by the FDA for treating hospitalised COVID-19 patients. This is a testament to the strength of @benevolent_ai's initial AI-derived hypothesis first published in @TheLancet in early February. https://t.co/sFwq7eKAt0
— Joanna Shields (@joannashields) November 20, 2020
The ACTT-2 trial results which validate our @benevolent_ai AI platform-derived hypothesis of baricitinib’s efficacy as a possible treatment for COVID-19 are truly encouraging. We are proud to contribute our research to aid the global pandemic response. https://t.co/skqhI4JiqH
— Joanna Shields (@joannashields) September 19, 2020
Casual gaming is also on the rise. People who play to burn off stress, rather than making gaming a crucial part of their identity, are joining the gamer ranks in droves. The question is: Is this a good thing? https://t.co/VRf44rKEAe
— WIRED (@WIRED) March 2, 2021
The Mayflower Autonomous Ship won’t be taking commands from a human captain like the first Mayflower did during its crossing back in 1620. Instead it will get orders from an “AI captain” built by programmers at IBM. https://t.co/bfMpxnzcbe
— WIRED (@WIRED) February 24, 2021
Drones With 'Most Advanced AI Ever' Coming Soon To Your Local Police Department https://t.co/druLDSXUTz pic.twitter.com/iVqm2km1wc
— Forbes (@Forbes) March 3, 2021
OCFA FIRIS Intel 24 on the Shannon Fire, Los Angeles County Fire Department in the Action CA area. pic.twitter.com/Ot9lIoNVQ0
— Joel Lane (@zunibirdjoel) February 25, 2021
If you've got ship-tracking software and are interested in following the @AI_Mayflower, especially when it comes to its transatlantic voyage (~mid-April), then it's had its AIS transponder switched on in recent trials. Keep an eye out! MMSI: 232032782 pic.twitter.com/947xGxjTwh
— Jonathan Amos (@BBCAmos) February 25, 2021
https://twitter.com/IBMData/status/1366784172010983430
https://twitter.com/EvaSmartAI/status/1366262570332602370
An #Aerospace company is planning to grow drones #Drones @iotnews_asia
#drone #UAV #tech #Robotics #AI #ML #100DaysOfCode #MachineLearning #future @MargaretSiegien
@Nicochan33
@mvollmer1
@rwang0
@jblefevre60
@JeroenBartelse
@ShiCooks
@SpirosMargaris pic.twitter.com/91CTcb2Amx— Automeme (@automeme) February 19, 2021
The system integrates perception, high level planning, and modular #hardware and is validated in three hardware demonstrations.
By @nature#Robotics #IoT #IIoT #5G #tech #AI #innovation #artificialintelligence
Cc: @mvollmer1 @jblefevre60 @Nicochan33 @sebbourguignon @chboursin pic.twitter.com/wthTrLYJDf— Fabrizio Bustamante (@Fabriziobustama) February 18, 2021
@CARIS_GIS has received significant funding from Canada’s Ocean Supercluster award to develop software for remote operations survey processing, in line with the company’s AI (#artificialintelligence) development strategy. Read more at @UnmannedSystem https://t.co/Z952bc1V8l
— Energy Drone & Robotics Coalition (@enrgdrone) March 2, 2021
Australian-made Loyal Wingman air combat drone with AI-driven targeting system completes first test flight – ABC News https://t.co/2NSlkiO0Mb #ai #artificialintelligence #aiaustralia #machinelearning #deeplearning pic.twitter.com/cgM65W2YFb
— AI Australia (@AustraliaAi) March 3, 2021
10 Ways AI And Machine Learning Are Improving Marketing In 2021 by @LouisColumbus via @forbes https://t.co/7p6KAdCm5U #AI #ML #martech #CMO
cc @tlloydjones @gerald_bader @Emma03391714 @wfcrittenden2 @GuidoKerkhof @ravidugh @enilev @Nicochan33 @NancyTr83158469 @RagusoSergio pic.twitter.com/3NCoEjDukp— BusinessIntelligence (@bimedotcom) February 22, 2021
The Science of Driving Naturally: How Self-Driving Vehicles Learn to Get Along with City Traffic https://t.co/tCUGaBbwlG #AutonomousVehicles #AI #ArtificialIntelligence #SmartTech #futureofmobility #Sensors #Planning
— QS2 Point (@QS2Point) February 22, 2021
Read this article to learn about the three most innovative features powered by #AI and #MachineLearning that you can expect to see in business applications in the next decade. https://t.co/4V7plsDoKN
— LMSSales (@sales_lms) February 18, 2021
J.B. Hunt is working with @googlecloud to develop AI technology for planning and moving freight, an increasingly digital and competitive part of the company’s business https://t.co/LIHBbGavmv via @WSJ
— Atle Erlingsson (@aerlings) February 18, 2021
Salesforce's AI ethics chief shares 3 ways to use tech when planning a safe return to the office (by @baxterkb) https://t.co/nVkqtf3pfO
— Business Insider Tech (@BITech) February 2, 2021
5 Things Your Company Should Know Before Investing in Artificial Intelligencehttps://t.co/Pht0Mwi6T6 via @Entrepreneur #AI #ML #Technology #ArtificialIntelligence pic.twitter.com/mKVx58Rhs9
— Digital Marketing Stream (@Digitalmstream) February 20, 2021
How Artificial Intelligence Will Disrupt The Email Marketing Industry https://t.co/xvunHvTp3p pic.twitter.com/e2O9kk0dVU
— R9 CloudTech (@R9CloudTech) February 17, 2021
Conversational marketing technology is utilizing developments in machine learning algorithms and artificial intelligence (AI) to facilitate machine-powered selling to consumers via the use of chatbots. #chatbots #ai #marketing https://t.co/h3MOxku24i
— kaskade (@kaskadecloud) February 22, 2021
Artificial Intelligence (AI) is currently being used in marketing and sales for all sorts of processes from personalized shopping to warehouse logistics. https://t.co/7BAh0ghcNE
— Lisa Kaye (@LisaKayeCAP) February 19, 2021
AI can help distributor’s outside sales teams bridge the Millennials Service Gap and fuel your company’s recovery post-COVID-19. https://t.co/zZJrSbOhy9#distributionsoftware #artificialintelligence #salestools #automation #ai pic.twitter.com/GTlCtvIchR
— proton.ai (@AiProton) February 16, 2021
Planning for the post-pandemic workplace, managing hybrid teams, and optimizing your organization for AI. https://t.co/VCxnV5dW6F
— MIT Sloan Management Review (@mitsmr) February 12, 2021
Companies are expected to spend $97.9 billion on AI by the end of 2023, but many initiatives fail or don’t turn a profit.https://t.co/eALmWYktdz
— MIT Sloan School of Management (@MITSloan) March 3, 2021
https://twitter.com/or_pippin/status/1360900337008316417
As predicted in my AI book, US society catching up with abusive AI practices that turn consumers into morons managed by others. India’s so-called “intellectuals” too busy obsessed w stupid issues while the ship heads for the iceberg! https://t.co/vIQQS0lUNG
— Rajiv Malhotra (@RajivMessage) February 26, 2021
When it comes to artificial intelligence, spy agencies have been at it longer than most https://t.co/fMnt6NwH6w
— The Economist (@TheEconomist) March 3, 2021